Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model

NCT03180801 is registered in ClinicalTrials.gov with PepTcell Limited as lead sponsor.

NCT NCT03180801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03180801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model
Lead sponsor
PepTcell Limited
Phase
Phase 2
Overall status
Completed
Start date
August 18, 2016
Completion date
May 25, 2017
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza